Literature DB >> 1535141

[Heart conduction disorders in long-term treatment with chloroquine. Two new cases].

C Verny1, C de Gennes, P Sébastien, H D Lê Thi, C Chapelon, J C Piette, G Chomette, P Godeau.   

Abstract

Cardiac complications are exceptional in long-term chloroquine therapy; congestive heart failure and restrictive cardiomyopathy may develop, but disorders of conduction are more frequent. The characteristics of these disorders emerge from 12 cases in the literature and from 2 personal cases. The usual disorder is fascicular block which may become a complete, syncopal, atrioventricular block, as in one of our 2 patients. The time elapsed between the beginning of treatment and the occurrence of these disorders (2 to 30 years) and the total dose of chloroquine received (100 to 2,500 g) are extremely variable. Retinopathy or neuromyopathy is present in 64 and 35 percent of the cases respectively. The diagnosis is confirmed by endomyocardial biopsy with electron microscopic study which shows vaculoar myopathy with numerous large secondary lysosomes containing a dense material of lamellar structure (myelinic figures, curvilinear bodies). Regression of heart conduction disorders after withdrawal of chloroquine seems to be inconstant and incomplete. The rare occurrence of this complication raises the question of genetic predisposition. We believe that chloroquine therapy should be contra-indicated in patients with a history of conduction disorders and that a 6-monthly electrocardiographic control of these patients would be justified.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1535141

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  7 in total

1.  Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Clin Res Cardiol       Date:  2009-02-09       Impact factor: 5.460

2.  Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature.

Authors:  Clotilde Chatre; François Roubille; Hélène Vernhet; Christian Jorgensen; Yves-Marie Pers
Journal:  Drug Saf       Date:  2018-10       Impact factor: 5.606

Review 3.  Histological and ultrastructural findings in chloroquine-induced cardiomyopathy.

Authors:  C August; H J Holzhausen; A Schmoldt; R Pompecki; S Schröder
Journal:  J Mol Med (Berl)       Date:  1995-02       Impact factor: 4.599

4.  Cardiotoxicity after low-dose chloroquine antimalarial therapy.

Authors:  Gabriele Fragasso; Francesca Sanvito; Francesca Baratto; Sabina Martinenghi; Claudio Doglioni; Alberto Margonato
Journal:  Heart Vessels       Date:  2009-09-27       Impact factor: 2.037

Review 5.  Cardiac and arrhythmic complications in patients with COVID-19.

Authors:  Adriano Nunes Kochi; Ana Paula Tagliari; Giovanni Battista Forleo; Gaetano Michele Fassini; Claudio Tondo
Journal:  J Cardiovasc Electrophysiol       Date:  2020-04-13

Review 6.  Coronavirus (COVID-19), Coagulation, and Exercise: Interactions That May Influence Health Outcomes.

Authors:  Emma Kate Zadow; Daniel William Taylor Wundersitz; Diane Louise Hughes; Murray John Adams; Michael Ian Charles Kingsley; Hilary Anne Blacklock; Sam Shi Xuan Wu; Amanda Clare Benson; Frédéric Dutheil; Brett Ashley Gordon
Journal:  Semin Thromb Hemost       Date:  2020-09-03       Impact factor: 4.180

7.  Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis?

Authors:  Jason S Chinitz; Rajat Goyal; Melissa Harding; Granit Veseli; Luis Gruberg; Ram Jadonath; Paul Maccaro; Puneet Gandotra; Lawrence Ong; Laurence M Epstein
Journal:  Pacing Clin Electrophysiol       Date:  2020-09-14       Impact factor: 1.912

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.